NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









UPyTher B.V.

UPyTher B.V.

Private
EindhovenHealthcare & Life Scienceshttps://www.upyther.com/

Last Round

Seed

Jun 10, 2024

Total Funding Raised

$3.47M

Company Overview

UPyTher B.V. is a pharmaceutical company that develops hydrogel-based drug delivery platforms for the treatment of peritoneal cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug deliverypolymer-drug conjugatehydrogeldrug delivery techbiotechnologydrug formulationcontrolled releaseoncologydrug solubilitybiotech platformsupramolecular chemistryintraperitoneal deliverybiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UPyTher B.V. Comparables

Compare UPyTher B.V. with similar companies based on industry and business-model similarity.

UPyTher B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PDC Therapeutics
87%
NaDeNo Nanoscience
86%
Serina Therapeutics Inc
79%

UPyTher B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 10, 2024
GrantApr 12, 2024
GrantDec 14, 2023

Key People

Founding team and executive leadership

Geert van Almen

CEO & Co-Founder of UPyTher B.V.

Founding Team

UPyTher B.V. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 12, 2026

    Partnered with Oncode Accelerator on a Demonstrator Project for peritoneal metastases.

  • Jun 10, 2024

    Received funding from Brabantse Ontwikkelings Maatschappij.

UPyTher B.V. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

UPyTher B.V. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about UPyTher B.V.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersEindhoven
Employee Range6
Year Founded2020
Last FundingJun 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.